Some aspects need to be considered in assessment and treatment of sarcopenia
- PMID: 30022815
- PMCID: PMC6044338
- DOI: 10.2147/CIA.S176216
Some aspects need to be considered in assessment and treatment of sarcopenia
Conflict of interest statement
Disclosure The authors declare no conflicts of interest in this communication.
Comment on
-
Sarcopenia: assessment of disease burden and strategies to improve outcomes.Clin Interv Aging. 2018 May 14;13:913-927. doi: 10.2147/CIA.S149232. eCollection 2018. Clin Interv Aging. 2018. PMID: 29785098 Free PMC article. Review.
References
-
- Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016;35(6):1557–1563. - PubMed
-
- Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) 2000;89(2):465–471. - PubMed
-
- Morley JE. Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int. 2016;98(4):319–333. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources